In the cerebrospinal fluid of 38 patients with major depressive disorders the purine metabolites hypoxanthine and xanthine were positively correlated to the monoamine metabolites HVA and 5HIAA (p < 00001). Hypoxanthine was also positively linked to the noradrenaline metabolite MHPG (p < 0 005). By bipolars. Twenty were females, mean age 41 (range 20-66) years, and 18 males, mean age 42 (range 22-57) years. No antidepressant or neuroleptic medication was allowed during a ten-day period before tests. Twelve patients were on regular benzodiazepine regimen, 16 used it irregularly during the investigation period, and 10 had no contact with this class of drugs. Only two patients had been treated with lithium at any time. The cerebrospinal fluid (CSF) was collected by lumbar puncture performed in a standardised manner as described previously. " A fixed volume of 13 ml was collected. The specimens were immediately frozen and 255 group.bmj.com on April 8, 2017 -Published by
Adenosine and its nucleotides are extensively involved in brain metabolism. Accumulated data also indicate that these compounds may act as neurotransmitters or neuromodulators in the central nervous system (for review see Phillis and Wu'). Adenine nucleotides are stored within brain cells with ATP being the prevalent form.2 During stimulation of central nervous structures in vitro and in vivo adenine nucleotides are released3" and then rapidly hydrolysed extracellularly to form the purine nucleosides. Further degradation results in hypoxanthine and xanthine; the end products of the purine metabolism, while the absence or very low amounts of xanthine oxidase in the brain7 is not consistent with the formation of urate. Recently we have noted that the hypoxanthine and xanthine concentrations in the cerebrospinal fluid of patients with major depressive disorders were strongly related to certain psychiatric variables including suicidal tendency, worrying and be published). Since + a a a o a g o a g o u , , , , , , , , , , , . + . . + + .
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.4++*++++*++++00* 0 +N--tzXttt tllilllii analysis of monoamine metabolites were carried out within two weeks by Professor Lars Svennerholm in Gothenburg according to a procedure described. 2 The monoamine metabolites analysed were homovanillic acid (HVA), 5-hydroxy-indoleacetic acid (5HIAA) and 3-methoxy-4-hydroxyphenyl glycol (MHPG Another way of demonstrating connections between purine and monoamine metabolites in CSF is by examining behavioural correlates shared in common. In another report, we have tried to show that, for example, memory disturbance during a depression is linked with higher levels of hypoxanthine in CSF, and worrying, suicidal tendencies and somatic anxiety to be connected with lower levels of xanthine (Agren et During cerebral ischaemia the intracellular concentrations of adenine and guanine di-and trinucleotide rapidly fall.2 22 In parallel with these events, the corresponding monophosphonucleotides increase in cerebral tissue. These consequences of decreased oxygen supply are reflected in increased hypoxanthine and xanthine concentrations in CSF (Hallgren et al, to be published). In this situation, the increased release of oxypurines is supposed to occur from an intracellular metabolic pool, rather than from a presynaptic vesicle pool. The purine metabolites in CSF may thus also reflect the brain metabolism and not only a balanced release from nervous structures. If so, the relationship found between hypoxanthine-xanthine and monoamine metabolites in CSF might reflect the influence of the brain metabolic rate on the monoamine synthesis, or, alternatively, the regulatory role of monoamines on the brain metabolism.
Evidence exists for behavioural changes due to nucleotide action. There are a number of reports describing sedative and anticonvulsant effects of adenine, adenosine and various adenosine analogues in experimental animals.23-26 The Lesch-Nyhan syndrome, an inherited disorder of purine metabolism with increased concentrations of urate and oxypurines in blood and CSF is characterised by mental retardation, psychomotor retardation and self-mutilation.27 It has also been suggested that some actions common to several groups of psychotherapeutic agents may be exerted by effects on adenosine and ATP in central neurons.' Like previous investigators, we found that affective symptoms such as suicidal measures and memory disturbance were connected with different CSF concentrations of 5HIAA and HVA.8 These symptoms were correlated in our patients with CSF levels of hypoxanthine and/or xanthine as well. Thus, certain behavioural variables appear to be least common denominators behind the purinergic and monoaminergic metabolism as reflected in CSF during depressive illness.
